ARCHIVES

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

Longer Infusion More Effective For Pancreatic Cancer

September 26, 2003

Plan To Reprogram $10 Million On Construction Funds Draws Criticism

November 19, 1976

Bush Increase For NIH In Sharp Contrast To Cuts In Health Delivery Programs.

April 6, 2001

Facing Congressional Criticism, NIH Starts Review of Extramural Conflict Policies.

June 13, 2008

Brain Gliomas Progress When Gene Function Is Lost

April 25, 2003

NIH Reauthorization Compromise Between House and Senate Gives NCI Three Year Authorization Period

October 18, 1985